COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,386 Articles (22,816 medRxiv, 8,570 bioRxiv)

Most recent first Previous |  Page 1155: Articles 11541-11550  | Next

Favipiravir In Adults with Moderate to Severe COVID-19: A Phase 3 Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial.
Shenoy, S., Munjal, S., Al Youha, S., Alghounaim, M., Almazeedi, S., Alshamali, Y., Kaszynski, R. H., Al-Sabah, S. K., Kuwait Clinical Trial Group
10.1101/2021.11.08.21265884 — Posted: 2021-11-09
Third dose vaccine With BNT162b2 and its response on Long COVID after Breakthrough infections
hoque, a., Rahman, M., Imam, H., Nahar, N., Hasan Chowdhury, F. U.
10.1101/2021.11.08.21266037 — Posted: 2021-11-09 Discussion: Onsite
Association of alcohol consumption and frequency with loneliness: A cross-sectional study among Japanese workers during the COVID-19 pandemic
Konno, Y., Okawara, M., Hino, A., Nagata, T., Muramatsu, K., Tateishi, S., Tsuji, M., Ogami, A., Fujino, Y.
10.1101/2021.11.05.21265962 — Posted: 2021-11-09
Three doses of COVID-19 mRNA vaccination are safe based on adverse events reported in electronic health records
Niesen, M. J. M., Pawlowski, C., O'Horo, J. C., Challener, D. W., Silvert, E., Donadio, G., Lenehan, P. J., Virk, A., Swift, M. D., Speicher, L., Geyer, H. L., Halamka, J., Venkatakrishnan, A. J., Soundararajan, V., Badley, A. D.
10.1101/2021.11.05.21265961 — Posted: 2021-11-09
Validation of a rapid and sensitive SARS-CoV-2 screening system developed for pandemic-scale infection surveillance
Dewhurst, R., Heinrich, T., Watt, P., Ostergaard, P., Marimon, J. M., Wood, D., Koks, S.
10.1101/2021.11.04.21265951 — Posted: 2021-11-09
Exploring Associations with Severe Hypoxemic Respiratory Failure in COVID-19 Patients upon Admission: A Model for Severe Hypoxemic Respiratory Failure in 329 Unvaccinated, Hospitalized COVID-19 Patients.
Davis, J. W., Wang, B., Tomczak, E., Fu, C.-C., Harmouch, W., Reynoso, D., Keiser, P., Cabada, M.
10.1101/2021.11.05.21265970 — Posted: 2021-11-09
Immunogenicity and safety of the homogenous booster shot of a recombinant fusion protein vaccine (V-01) against COVID-19 in healthy adult participants primed with a two-dose regimen
Li, Y., Fang, X., Pei, R., Fan, R., Chen, S., Zeng, P., Ou, Z., Deng, J., Zhou, J., Sun, Z., Liu, L., Peng, H., Chen, X., Su, Z., Chen, X., He, J., Guan, W., Hu, Z., Fu, Y.-X., Zhang, J.
10.1101/2021.11.04.21265780 — Posted: 2021-11-08
SARS-CoV-2 Antibody Response is Associated with Age in Convalescent Outpatients
Zhai, B., Clarke, K., Bauer, D. L., Kupul, S., Schratz, L. J., Nowalk, M. P., McElroy, A. K., McLachlan, J. B., Zimmerman, R. K., Alcorn, J. F.
10.1101/2021.11.08.21265888 — Posted: 2021-11-08
Anti-membrane and anti-spike antibodies are long-lasting and together discriminate between past COVID-19 infection and vaccination
Amjadi, M. F., Adyniec, R. R., Gupta, S., Bashar, S. J., Mergaert, A. M., Braun, K. M., Moreno, G. K., O'Connor, D. H., Friedrich, T. C., Safdar, N., McCoy, S. S., Shelef, M. A.
10.1101/2021.11.02.21265750 — Posted: 2021-11-08
An interactome landscape of SARS-CoV-2 virus-human protein-protein interactions by protein sequence-based multi-label classifiers
Lee, H.-J.
10.1101/2021.11.07.467640 — Posted: 2021-11-08

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).